Biovet JSC (LTS:0III) Total Assets: лв336.29 Mil (As of Dec. 2016)


What is Biovet JSC Total Assets?

Biovet JSC LTS:0III Total Assets is лв336.29 Mil as of Dec. 2016. The stock has 1 warning sign investors should review.

Biovet JSC's Total Assets for the quarter that ended in Dec. 2016 was лв336.29 Mil.

Warning Sign:

If a company builds asset at 12.5% a year, faster than its revenue growth rate of 10.6% over the past 5 years, it means that the company may be getting less efficent.

During the past 12 months, Biovet JSC's average Total Assets Growth Rate was 24.10% per year. During the past 3 years, the average Total Assets Growth Rate was 14.80% per year. During the past 5 years, the average Total Assets Growth Rate was 12.50% per year.

During the past 8 years, Biovet JSC's highest 3-Year average Total Assets Growth Rate was 17.50%. The lowest was 8.50%. And the median was 14.80%.

Total Assets is connected with ROA %. Biovet JSC's annualized ROA % for the quarter that ended in Dec. 2016 was 6.33%. Total Assets is also linked to Revenue through Asset Turnover. Biovet JSC's Asset Turnover for the quarter that ended in Dec. 2016 was 0.21.

Biovet JSC  (LTS:0III) Total Assets Explanation

Total Assets is connected with ROA %.

Biovet JSC's annualized ROA % for the quarter that ended in Dec. 2016 is

ROA %=Net Income (Q: Dec. 2016 )/( (Total Assets (Q: Sep. 2016 )+Total Assets (Q: Dec. 2016 ))/ count )
=20.576/( (313.317+336.286)/ 2 )
=20.576/324.8015
=6.33 %

Note: The Net Income data used here is four times the quarterly (Dec. 2016) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Biovet JSC's Asset Turnover for the quarter that ended in Dec. 2016 is

Asset Turnover
=Revenue (Q: Dec. 2016 )/( (Total Assets (Q: Sep. 2016 )+Total Assets (Q: Dec. 2016 ))/ count )
=68.111/( (313.317+336.286)/ 2 )
=68.111/324.8015
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Biovet JSC Total Assets Related Terms

Biovet JSC Total Assets Historical Data

* Premium members only.

The historical data trend for Biovet JSC's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC Total Assets Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Assets
Get a 7-Day Free Trial 212.21 223.80 241.86 276.14 336.29

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 276.14 287.86 296.16 313.32 336.29

Biovet JSC Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Biovet JSC's Total Assets for the fiscal year that ended in Dec. 2016 is calculated as

Total Assets=Total Equity (A: Dec. 2016 )+Total Liabilities (A: Dec. 2016 )
=131.771+204.515
=336.29

Biovet JSC's Total Assets for the quarter that ended in Dec. 2016 is calculated as

Total Assets=Total Equity (Q: Dec. 2016 )+Total Liabilities (Q: Dec. 2016 )
=131.771+204.515
=336.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of лв336.29 Mil mean?
Biovet JSC (LTS:0III) has a Total Assets of лв336.29 Mil as of Dec. 2016. The total amount of assets as recorded on a company's balance sheet. View historical data on Biovet JSC and its competitors.
Is Biovet JSC's Total Assets too high?
Biovet JSC's current Total Assets is лв336.29 Mil.
How does Biovet JSC's Total Assets compare to ADMP and AGRX?
Biovet JSC's Total Assets of лв336.29 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Biovet JSC and its competitors. Biovet JSC's current Total Assets is лв336.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Total Assets of лв336.29 Mil. The current Total Assets is лв336.29 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Total Assets is лв336.29 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.